Eric Cruz

Eric Cruz has a diverse work experience, starting from their position as a Graduate Student at the University of Nebraska Medical Center from September 2010 to April 2017. Eric then joined Catalent Pharma Solutions, where they worked as a Biologics Scientist and later as a Lead Scientist from July 2017 to May 2020. Following that, they joined Nectagen, Inc. as a Research Scientist from May 2020 to February 2022. Currently, they are employed as a Method Development Scientist at Celerion starting from February 2022.

From 2010 to 2016, Eric Cruz attended the University of Nebraska Medical Center, where they obtained their Doctor of Philosophy (PhD) degree in Biochemistry and Molecular Biology.